CUTTER CAPITAL MANAGEMENT
CUTTER CAPITAL MANAGEMENT, LP Legal Name
Adviser information for CUTTER CAPITAL MANAGEMENT last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 7 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 3 | $387.2M |
Non-Discretionary | 0 | $0 |
Total | 3 | $387.2M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $387.2M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 100 |
No. of Financial Planning Clients | 0 |
Services
Advisory Services | Portfolio management for businesses or institutional clients |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
1330 AVENUE OF THE AMERICAS33RD FLOOR
NEW YORK
NY
United States
Monday - Friday, 9AM - 5PM
Tel: 646-989-4200, Fax: None
Chief Compliance Officer
KERRY KOUREPENOS
CHIEF OPERATING OFFICER AND PARTNER
1330 AVENUE OF THE AMERICAS
33RD FLOOR
NEW YORK
NY
United States
Tel:
(646) 989-4203
K****@************M
(Full email address available in API data)
Regulatory Contact
VINCENT AITA
CHIEF INVESTMENT OFFICER AND MANAGING PARTNER
1330 AVENUE OF THE AMERICAS
33RD FLOOR
NEW YORK
NY
United States
Tel:
(646) 989-4201
V****@************M
(Full email address available in API data)
Industry Affiliates
None |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|
None
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
AITA, VINCENT, MICHAEL | Individual | – | CHIEF INVESTMENT OFFICER AND MANAGING PARTNER | 08/2022 | > 75% |
CUTTER CAPITAL MANAGEMENT GP, LLC | Domestic Entity | – | GENERAL PARTNER | 08/2022 | < 5% |
AITA, VINCENT, MICHAEL | Individual | CUTTER CAPITAL MANAGEMENT GP, LLC | MANAGING MEMBER | 08/2022 | > 75% |
CHUNG, MI-OK, NMN | Individual | CUTTER CAPITAL MANAGEMENT GP, LLC | MEMBER | 08/2022 | |
KOUREPENOS, KERRY, STEVEN | Individual | – | CHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER, AND PARTNER | 04/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
AMGEN INC | COM | 20M | 64K | – |
ARCELLX INC | COMMON STOCK | 10M | 187K | – |
AVADEL PHARMACEUTICALS PLC | COM SHS | 10M | 733K | – |
AVANTOR INC | COM | 8M | 400K | – |
BIOCRYST PHARMACEUTICALS INC | COM | 12M | 2M | – |
BIOGEN INC | COM | 18M | 77K | – |
BIOMARIN PHARMACEUTICAL INC | COM | 23M | 274K | – |
BRIDGEBIO PHARMA INC | COM | 8M | 312K | – |
CRISPR THERAPEUTICS AG | NAMEN AKT | 11M | 201K | – |
CYTOKINETICS INC | COM NEW | 13M | 237K | – |
ENLIVEN THERAPEUTICS INC | COM | 5M | 223K | – |
EVOLUS INC | COM | 5M | 465K | – |
GILEAD SCIENCES INC | COM | 20M | 293K | – |
HARMONY BIOSCIENCES HLDGS IN | COM | 9M | 296K | – |
INSMED INC | COM PAR $.01 | 15M | 228K | – |
IONIS PHARMACEUTICALS INC | COM | 8M | 160K | – |
KENVUE INC | COM | 17M | 960K | – |
LEGEND BIOTECH CORP | SPONSORED ADS | 15M | 343K | – |
MERCK & CO INC | COM | 22M | 176K | – |
PERRIGO CO PLC | SHS | 3M | 100K | – |
PFIZER INC | COM | 5M | 185K | – |
ROYALTY PHARMA PLC | SHS CLASS A | 18M | 692K | – |
SAREPTA THERAPEUTICS INC | COM | 14M | 89K | – |
SAREPTA THERAPEUTICS INC | COM | 3M | 20K | – |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 15M | 912K | – |
ULTRAGENYX PHARMACEUTICAL IN | COM | 15M | 365K | – |
VERA THERAPEUTICS INC | CL A | 8M | 230K | – |